Physician
Oncology
Dr. Nikolay V. Dimitrov, MD
|
|
Give Review
Nikolay Dimitrov works in the field of Oncology. He went to Medical University of Sofia FOM. Nikolay V. Dimitrov is a published physician. He has 36 publications published. The most current publication "Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- HER2 status in elderly women with Breast cancer.
- Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic Cancers.
- Some aspects of the endocrine profile and management of hormone-dependent male Breast cancer.
- Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tu...
- Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz.
- Endothelin-1 enriched tumor phenotype predicts Breast cancer recurrence.
- [Provocation of labor activity by oral administration of methylergobasine (methergine) by Merger''s method (R. Merger)].
- Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
- Treatment of primary Breast cancer with chemotherapy and tamoxifen.
- Tamoxifen for prevention of Breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
- A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative Breast cancer who have estrogen-receptor-positive tumors.
- Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative Breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.
- Tamoxifen in treatment of intraductal Breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
- Long-term tamoxifen citrate use and potential ocular toxicity.
- ATP-ase activity of lymphocytes from normal individuals and patients with Cancer.
- Systemic therapy of Breast cancer in early and advanced disease.
- Effect of thymosin (fraction 5) on the plasma levels of glucose and glucoregulatory hormones in humans.
- Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive Breast cancer.
- Five versus more than five years of tamoxifen therapy for Breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
- Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.
- Bioavailability of beta-carotene in humans.
- A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy.
- High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon Cancer.
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node Breast cancer patients aged 50 years and older with tumors res...
- Non-small-cell lung Cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome.
- The effect of selenium on phagocytosis in humans.
- Plasma tocopherol concentrations in response to supplemental vitamin E.
- Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
- Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 Breast tumor cells.
- Breast cancer metastatic to the eye is a common entity.
- Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced Breast cancer.
- Some aspects of vitamin E related to humans and Breast cancer prevention.
- High-performance liquid chromatographic method for the analysis of Oltipraz in human serum and urine.
- Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E.
- Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies.
Schools
Med AcademyHigher Med Institute
Metrohealth Med Center
Conditions Treated
- Breast Cancer
- Lung Cancer
- Myeloma
- Ovarian Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Case Western Reserve University - MetroHealth -
Medical University of Sofia FOM
Hospital
-
McLaren Greater Lansing
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609811793 |
| Last Name Of The Provider | DIMITROV |
| First Name Of The Provider | NIKOLAY |
| View All |
Similar Doctors
|
|
Dr. Kenneth A. Schwartz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl D. Kovalski, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shalini Thoutreddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian W. Olsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James G. Herman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara A. Conley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anas Al-Janadi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aisha Ahmed, MD |
|
|
Dr. Vijay Chaudhary, MD
This Doctor is OpenDoctor Recommended.
|